Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2023-02-21 17:18:28 UTC |
---|
HMDB ID | HMDB0015319 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Ciclopirox |
---|
Description | Ciclopirox is only found in individuals that have used or taken this drug. It is a synthetic antifungal agent for topical dermatologic use. [Wikipedia ] Unlike antifungals such as itraconazole and terbinafine, which affect sterol synthesis, ciclopirox is thought to act through the chelation of polyvalent metal cations, such as Fe3+ and Al3+. These cations inhibit many enzymes, including cytochromes, thus disrupting cellular activities such as mitochondrial electron transport processes and energy production. Ciclopirox also appears to modify the plasma membrane of fungi, resulting in the disorganization of internal structures. The anti-inflammatory action of ciclopirox is most likely due to inhibition of 5-lipoxygenase and cyclooxygenase. Ciclopirox may exert its effect by disrupting DNA repair, cell division signals and structures (mitotic spindles) as well as some elements of intracellular transport. |
---|
Structure | CC1=CC(=O)N(O)C(=C1)C1CCCCC1 InChI=1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3 |
---|
Synonyms | Value | Source |
---|
6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone | ChEBI | Ciclopiroxum | ChEBI | Loprox | Kegg | Penlac | Kegg | Ciclopirox olamin | HMDB | Ciclopirox-olamin | HMDB | Ciclopiroxolamine | HMDB | HOE 296b | HMDB | HOE-296b | HMDB | HOE 296 | HMDB | Cyclopirox | HMDB | Cyclopyroxolamine | HMDB | Batrafen | HMDB | Dafnegin-CSC | HMDB | Ciclopirox olamine | HMDB | 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt | HMDB | HOE-296 | HMDB | Dafnegin CSC | HMDB |
|
---|
Chemical Formula | C12H17NO2 |
---|
Average Molecular Weight | 207.2689 |
---|
Monoisotopic Molecular Weight | 207.125928793 |
---|
IUPAC Name | 6-cyclohexyl-1-hydroxy-4-methyl-1,2-dihydropyridin-2-one |
---|
Traditional Name | penlac |
---|
CAS Registry Number | 29342-05-0 |
---|
SMILES | CC1=CC(=O)N(O)C(=C1)C1CCCCC1 |
---|
InChI Identifier | InChI=1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3 |
---|
InChI Key | SCKYRAXSEDYPSA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyridinones. Pyridinones are compounds containing a pyridine ring, which bears a ketone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Hydropyridines |
---|
Direct Parent | Pyridinones |
---|
Alternative Parents | |
---|
Substituents | - Methylpyridine
- Pyridinone
- Dihydropyridine
- Heteroaromatic compound
- Lactam
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 144 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.41 g/L | Not Available | LogP | 2.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ciclopirox GC-MS (Non-derivatized) - 70eV, Positive | splash10-02vi-1900000000-b0302ddc025a747a3484 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ciclopirox GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 10V, Positive-QTOF | splash10-0a4i-0390000000-1d9227c74bcc86583df3 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 20V, Positive-QTOF | splash10-0a4i-2690000000-963d9e37afedc3b4a600 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 40V, Positive-QTOF | splash10-05mo-9600000000-de9b944829cc25a5681b | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 10V, Negative-QTOF | splash10-0a4i-3090000000-ac55f8f5496920dc9ca4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 20V, Negative-QTOF | splash10-0a4i-0490000000-6cd8e595360c6bddf33a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 40V, Negative-QTOF | splash10-0a6r-5900000000-7869913422c2e64d2101 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 10V, Positive-QTOF | splash10-0a4i-0090000000-69c98b0c95a4f7a6ef58 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 20V, Positive-QTOF | splash10-0a4i-4490000000-d28507b6dbcfe8f98141 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 40V, Positive-QTOF | splash10-066r-9700000000-4dafee1a9eed2bbabe7b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 10V, Negative-QTOF | splash10-0a4i-0090000000-bc1578d935014f0ac50f | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 20V, Negative-QTOF | splash10-05is-6930000000-c7140620c24b41758ee7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ciclopirox 40V, Negative-QTOF | splash10-0f6x-9400000000-8c3e2f33da6d3911ea34 | 2021-10-11 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Membrane (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01188 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01188 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01188 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2647 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Ciclopirox |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2749 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 453011 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Niewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B: Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother. 2003 Jun;47(6):1805-17. [PubMed:12760852 ]
- Sigle HC, Thewes S, Niewerth M, Korting HC, Schafer-Korting M, Hube B: Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. J Antimicrob Chemother. 2005 May;55(5):663-73. Epub 2005 Mar 24. [PubMed:15790671 ]
- Qadripur SA: [Antimycotic therapy. 2. Antimycotic chemotherapeutic agents: imidazole derivatives, tolciclate, haloprogin, ciclopiroxolamin]. Fortschr Med. 1983 Mar 10;101(9):355-63. [PubMed:6303928 ]
- Beikert FC, Le MT, Koeninger A, Technau K, Clad A: Recurrent vulvovaginal candidosis: focus on the vulva. Mycoses. 2011 Nov;54(6):e807-10. doi: 10.1111/j.1439-0507.2011.02030.x. Epub 2011 May 25. [PubMed:21615545 ]
|
---|